Home Recalls D-0250-2026
Class II · Moderate risk Ongoing Initiated Dec 18, 2025 (9 months ago)
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Presence of particulate matter - Glass like particles.
What was recalled
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.
Recalling firm Imprimis NJOF, LLC
NDC code 71384-513-01
Origin NJ, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0250-2026
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Dexamethasone recalls
See all
Class II · Moderate risk Ongoing Feb 4, 2026
Reason Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were…
Class II · Moderate risk Ongoing Dec 18, 2025
Reason Presence of particulate matter - Glass like particles.
Class II · Moderate risk Ongoing Aug 13, 2025
Reason Temperature Abuse
Class II · Moderate risk Ongoing Apr 15, 2025
Reason Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024…
Class II · Moderate risk Ongoing May 23, 2024
Reason Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.